Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran

被引：0
作者：
Ali Mirzazadeh
Samira Hosseini-Hooshyar
Armita Shahesmaeili
Ali Bahramnejad
Adibeh Barshan
Ghazal Mousavian
Esmail Najafi
Hamid Sharifi
Ali-Akbar Haghdoost
Alya Briceno
Willi McFarland
Kimberly Page
机构：
[1] Kerman University of Medical Sciences,HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health
[2] University of California San Francisco,Department of Epidemiology and Biostatistics, Institute for Global Health Sciences
[3] The Kirby Institute,Epidemiology, Biostatistics and Preventive Medicine, Department of Internal Medicine
[4] UNSW Sydney,undefined
[5] Kerman University of Medical Sciences,undefined
[6] University of California San Francisco,undefined
[7] University of New Mexico Health Sciences Center,undefined
来源：
Substance Abuse Treatment, Prevention, and Policy | / 15卷
关键词：
People who inject drugs; Longitudinal cohort study; Barriers; Motivators; Iran;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 301 条
  • [1] Day C(2006)Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran Harm Reduct J 3 2-152
  • [2] Nassirimanesh B(2016)National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran Int J Drug Policy 31 147-iii32
  • [3] Shakeshaft A(2013)HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey Sex Transm Infect 89 iii29-98
  • [4] Dolan K(2018)Prevalence of hepatitis C virus infection among high-risk groups in Iran: a systematic review and meta-analysis Public Health 161 90-1603
  • [5] Nikfarjam A(2018)The epidemiology of hepatitis C virus in Iran: systematic review and meta-analyses Sci Rep 8 150-435
  • [6] Shokoohi M(2019)Dual unsafe injection and sexual behaviors for HIV infection among people who inject drugs in Iran AIDS Behav 23 1594-83
  • [7] Shahesmaeili A(2017)Lurking epidemic of hepatitis C virus infection in Iran: a call to action World J Hepatol 9 1040-130
  • [8] Haghdoost AA(2006)HIV/AIDS harm reduction in Iran Lancet 368 434-iiii6
  • [9] Baneshi MR(2015)Drug use treatment and harm reduction programs in Iran: a unique model of health in the most populated Persian Gulf country Asian J Psychiatr 16 78-187
  • [10] Haji-Maghsoudi S(2018)Estimation of HIV incidence and its trend in three key populations in Iran PLoS One 13 e0207681-1126
12345678910